1. Home
  2. Services
  3. Drug Screening and Toxicity Assessment
  4. High-Throughput Drug Screening

High-Throughput Drug Screening

The Significance of High-Throughput Drug Screening

High-throughput screening is a technique extensively used in drug discovery to quickly test the biological or biochemical activity of many compounds. This process involves the use of robotics, data processing software, and sensitive detectors to conduct millions of tests rapidly. High-throughput screening is crucial for identifying active compounds, antibodies, or genes that can modulate specific biomolecular pathways, providing essential starting points for drug design and understanding biological interactions. At Protein Array, we leverage cutting-edge technologies to streamline the drug discovery process, drawing on insights from leading industry innovations.

High-throughput screening matters because it allows drug discovery to happen quickly by giving researchers access to large libraries of compounds. This ability is essential for meeting high-demand clinical issues - like antibiotic resistance - by spotting potential inhibitors to help rehabilitate current drugs. Automation and miniaturization of High-throughput screening cut cost and boost throughput and make it one of the foundations of the new pharma research.

High-Throughput Drug Screening Services

Creative Diagnostics offers High Throughput Drug Screening with near-infrared microarray protein chip technology for drug development and safety analysis.

Our services can help researchers achieve:

  • High-Capacity Workcell Automation
    To enhance throughput and reproducibility, we utilize high-capacity workcells designed for complex compound screens. These automated systems allow us to process a large number of plates per day with minimal error rates, thanks to duplicate instruments and robust error-handling capabilities. This automation not only increases data generation but also ensures consistent quality across assays.
  • Biochip Array Technology for Multiplex Testing
    The integration of Biochip Array Technology (BAT) into our workflow allows for simultaneous multi-analyte screening, providing comprehensive immunoassay profiles within minutes. This technology supports cost-effective and flexible testing solutions, capable of detecting a wide range of drugs and metabolites across various matrices.
  • High-Density Protein Microarrays
    We supply high density microarrays for high throughput protein screening and drug target identification. That way, we can quickly compare hundreds of proteins against different conditions or agents. For instance, scientists can calculate antibody affinities against particular antigens, or the impact of drugs candidates on target proteins. Another critical application is drug target identification. The way in which proteins bind to potential drug molecules will tell us who might be good candidates for a drug. The ability to screen multiple targets simultaneously accelerates the drug discovery process and enhances the chances of finding effective treatments.

Protein Array's Near-Infrared Microarray Protein Chip Technology Platform

Protein Array offers a cutting-edge near-infrared microarray protein chip technology platform that enhances the capabilities of high-throughput drug screening. Our platform combines technologies such as laser confocal microscopy, near-infrared fluorescent labeling chip, and special functional silica gel matrix membrane with protein chips to improve detection sensitivity and specificity, allowing for more precise analysis of protein interactions and drug effects.

Illustration of High-throughput Screening

Key features of our technology include:

  • Enhanced Sensitivity and Specificity: The use of near-infrared technology allows for better detection limits compared to traditional methods, reducing false positives and improving the reliability of screening results.
  • Reduced Sample Volume Requirements: The microarray format significantly decreases the amount of sample needed for each test, lowering costs and enabling the testing of more expensive or scarce compounds.
  • Automation and High Throughput: This platform supports automated processes that can handle large numbers of samples simultaneously, increasing efficiency and throughput.
  • Versatility: The platform can be used for multi-indicator joint detection. It is also applicable to a range of applications, such as enzyme inhibition experiments or protein-protein interactions analysis, and is thus an all-rounder in drug discovery.

Examples of Array Combination

CombinationMain Screening Objective
1. Kinase Panel Array + Small-Molecule Library Array- Identify inhibitors of specific kinases
- Rapidly assess selectivity and potency across a broad kinome
2. Receptor-Ligand Interaction Array + Fragment-Based Screening Array- Discover compounds (fragments or small molecules) that bind specific receptors
- Map binding affinities and potential sites of action
3. Proteome Array + Functional Antibody Array (for Phenotypic Screening)- Measure changes in expression or modification of hundreds/thousands of proteins upon drug treatment
- Identify novel drug targets or pathways affected
4. Phospho-Signaling Array + Cell Viability/Toxicity Array- Evaluate how compounds affect critical signaling nodes (e.g., MAPK, PI3K/Akt, JAK/STAT)
- Correlate signaling inhibition with cytotoxic or cytostatic effects
5. Epigenetic Enzyme Array + Phenotypic Screen (e.g., Reporter Gene Array)- Discover modulators of histone-modifying enzymes (HDACs, HATs, DNMTs, etc.)
- Link epigenetic modulation to downstream gene expression changes

Application of High-Throughput Drug Screening

The near-infrared microarray protein chip technology platform can be applied in several scenarios:

  • Drug Discovery
    It is used to screen potential drug candidates against various targets rapidly, helping identify promising leads early in the development process.
  • Biomolecular Interaction Studies
    The platform supports research of intricate protein interactions which helps scientists comprehend disease mechanisms and find therapeutic targets.
  • Enzyme Inhibition Analysis
    This technology helps to determine what drugs are the real inhibitors, as opposed to the generic aggregators, which help in drug discovery.

Microarray Service Workflow

Leveraging the advanced near-infrared microarray protein chip technology platform from Protein Array, Creative Diagnostics is dedicated to helping researchers perform high-throughput screening, providing greater accuracy, efficiency, and versatility to drug discovery efforts while dramatically accelerating the drug development process.

Online Inquiry
Services